The Ministry of Health and Prevention (MOHAP) in the United Arab Emirates has released the UAE National Infection Prevention and Control Guidelines 2026, a comprehensive document published on March 4, 2026, aimed at strengthening the nation's defenses against healthcare-associated infections (HAIs) and antimicrobial resistance (AMR). This timely update aligns with the UAE's National Action Plan on Antimicrobial Resistance (NAP-AMR) 2025-2031, emphasizing a 'One Health' approach to reduce infection rates, optimize antimicrobial use, and mitigate the growing threat of drug-resistant pathogens. As AMR continues to pose a global crisis—potentially causing 10 million deaths annually by 2050—these guidelines provide evidence-based protocols tailored to UAE healthcare settings, targeting hospitals, clinics, and long-term care facilities nationwide.

Developed under the oversight of the National IPC Subcommittee within the Higher Committee for AMR, the guidelines draw from international standards like those from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), while addressing local challenges such as high multidrug-resistant organism (MDRO) prevalence. They outline a structured IPC program to prevent HAIs, protect healthcare workers (HCWs), patients, and visitors, and integrate seamlessly with antimicrobial stewardship efforts. This publication marks a pivotal step in UAE's commitment to public health resilience, especially as recent surveillance data reveals concerning resistance trends.

🛡️ The Growing AMR Challenge in the UAE: Why These Guidelines Matter Now

Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites evolve to withstand drugs designed to kill them, rendering standard treatments ineffective. In the UAE, national surveillance from 2024 reported 198,771 non-duplicate isolates, highlighting alarming resistance levels: 47.7% of Escherichia coli were multidrug-resistant (MDR), 40.7% of Staphylococcus aureus were methicillin-resistant (MRSA), and carbapenem-resistant Enterobacterales (CRE) reached 3.4% for imipenem. Compared to 2023, trends show increases in MDR for key pathogens like Klebsiella pneumoniae (29.7%) and Enterococcus faecium (31.6%), underscoring the urgency of prevention.

Healthcare-associated infections exacerbate AMR, with HAIs linked to invasive devices, prolonged stays, and antibiotic overuse. Although specific 2025 HAI rates are pending full reporting, prior data indicate significant burdens, contributing to treatment failures and economic strain—estimated at hundreds of millions in additional costs regionally. The guidelines target this by prioritizing surveillance for device-associated HAIs like central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), and surgical site infections (SSI), using national key performance indicators (KPIs) for benchmarking. For professionals in higher education, this signals opportunities in training future HCWs through programs at institutions like higher-ed-jobs in public health and nursing.

UAE's NAP-AMR 2025-2031: Laying the Foundation

The NAP-AMR 2025-2031, overseen by MOHAP and multisectoral partners, structures UAE's response across six pillars: governance, awareness, surveillance, IPC, stewardship, and One Health integration. IPC is central, mandating national guidelines by 2026—fulfilled by this publication—to enforce training, HAI surveillance, and compliance audits. Actions include annual facility audits (>95% compliance target), mandatory IPC staffing (1 practitioner per 100 beds), and 5-10% yearly increases in surveillance participation.

Surveillance expansion covers human, animal, and environmental sectors, with WHONET software adoption and whole-genome sequencing for outbreaks. Stewardship focuses on reducing inappropriate use (e.g., <20% over-the-counter dispensing by 2028), informed by local antibiograms. The 2026 guidelines operationalize these, providing tools for MDRO management and HAI prevention to curb AMR spread.

Core Structure of the Guidelines: A Comprehensive Framework

Spanning over 200 pages, the guidelines are divided into 12 main sections, starting with the IPC program framework and risk assessment tools. Facilities must establish multidisciplinary IPC committees meeting quarterly, conduct annual risk assessments using matrices for high-volume/high-risk activities, and develop action plans integrated with quality improvement.

Key elements include standardized surveillance using CDC/NHSN definitions, multimodal hand hygiene strategies, and protocols for environmental controls during construction. Monitoring encompasses HAI trends, MDRO incidence, and antibiotic audits, with benchmarks against national/UAE data. For higher education, universities play a vital role in disseminating these through curricula—explore higher-ed-career-advice for roles in IPC education.

Standard Precautions and Transmission-Based Measures

Standard precautions form the bedrock: hand hygiene (WHO's 5 Moments), PPE selection based on risk, respiratory etiquette, safe injections, and proper handling of linens, waste, and specimens. Transmission-based precautions layer on: contact (for MDROs like CRE), droplet (influenza), and airborne (TB), with single-room placement and duration per CDC tables.

MDRO management targets MRSA, VRE, CRE, MDR-Acinetobacter, and Candida auris, recommending active surveillance, isolation, environmental screening, decolonization, and discharge planning. These measures directly reduce AMR selection pressure.

🚨 Hand Hygiene, Aseptic Technique, and Device Bundles

Hand hygiene employs a multimodal approach: system change (products available), training (annual), observation (WHO method), and feedback. Alcohol-based rubs for most, soap for C. difficile; monitor compliance targeting >90%.

Aseptic non-touch technique (ANTT) guides clean/surgical procedures. Bundles prevent device HAIs:

• CLABSI: Site selection (subclavian preferred), maximal barriers, chlorhexidine prep, daily reviews, securement.
• CAUTI: Indication-based insertion, closed systems, daily necessity checks.
• SSI: Glycemic control, normothermia, oxygenation, timely antibiotics.

Surveillance and National KPIs: Data-Driven Defense

HAI surveillance uses targeted/risk-based methods, calculating rates (e.g., CLABSI/1000 line-days), proportions, and incidence. KPIs track SSI (post-op cases), CLABSI/CAUTI/VAE rates, hand hygiene compliance. Facilities report to MOHAP for benchmarking, outbreak detection.

2024 data shows MDR burdens, justifying intensified surveillance. Quarterly committee reviews drive interventions.

Implementation Roadmap: Training, Monitoring, and Challenges

Rollout mandates IPC staffing, orientation training for all HCWs, competency assessments, and annual fit-testing for respirators. Facilities audit compliance during licensing; MOHAP provides workshops. Challenges include resource gaps in primary care, addressed via train-the-trainer models.

Case studies from UAE hospitals demonstrate multimodal IPC reducing CLABSI by 50-70% via bundles. Universities like UAEU and Khalifa support through research and UAE higher-ed programs.

Stakeholder Perspectives and Regional Impact

Experts at ICAMR conferences praise the guidelines for local adaptation. Policymakers highlight One Health synergies; HCWs note practical bundles. Impacts: lower HAIs/AMR, cost savings, safer care. For academics, fosters collaborations—check research-jobs in epidemiology.

Photo by Markus Winkler on Unsplash

Future Outlook: Towards AMR Elimination

With ICAMR 2026 approaching, these guidelines position UAE as a leader. Targets: 10% AMR mortality reduction by 2031. Higher ed must innovate training; visit higher-ed-jobs, rate-my-professor, higher-ed-career-advice, university-jobs for opportunities. Post a job at post-a-job.